RPL38P5

Across TCGA pan-cancer cohorts, RPL38P5 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RPL38P5 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RPL38P5 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL38P5 expression acts as an unfavorable survival marker, although some lineages such as HNSC and OV show a favorable association.

HNSC, KIRC, and OV are the cancer types where RPL38P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	II,III,IV	0.662	0.526	<.001	130	view →
KIRC	DFS	Quartile	All	0.513	0.689	.002	57	view →
OV	DFS	Quartile	All	0.261	0.140	.009	36	view →
COAD	OS	Median	IV	0.232	0.787	.003	31	view →
CESC	OS	Tertile	IV	0.754	0.242	.001	28	view →
PRAD	OS	Median	All	0.764	0.973	.003	28	view →
ESCA	DFS	Tertile	III,IV	0.597	0.258	.001	18	view →
UCEC	OS	Median	All	0.844	0.902	.028	16	view →
ACC	DFS	Median	III,IV	0.816	0.297	.006	15	view →
LGG	DFS	Median	All	0.768	0.878	.008	13	view →
LIHC	DFS	Quartile	All	0.439	0.596	.009	12	view →
LUSC	DFS	Median	II,III,IV	0.622	0.856	.008	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

RPL38P5–HNSC (DFS)

Open the HNSC breakdown →